Shorter tuberculosis treatment
Showing 1 - 25 of 2,716
Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)
Recruiting
- Tuberculosis, Pulmonary
- rifampicin
- +3 more
-
Linköping, SwedenLinköping University Hospital
Aug 19, 2021
Innovating(IN) Shorter(S), All- Oral, Precised(P),
Not yet recruiting
- Multidrug Resistant Tuberculosis
- This is a non-intervention observational study.
-
Guiyang, Guizhou, China
- +4 more
Oct 5, 2021
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)
Not yet recruiting
- Pulmonary Tuberculosis
- Rifampicin-resistant Tuberculosis
- Bedaquiline
- +11 more
-
Beijing, Beijing, China
- +37 more
Oct 11, 2023
Multidrug Resistant Tuberculosis Trial in China (PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter
Recruiting
- Multidrug Resistant Tuberculosis
- PZA sensitivity guided ultra-short all Oral Regimen
- Standardized Shorter Regimen
-
Shenzhen, Guangzhou, China
- +13 more
Jul 22, 2020
Strengthening Evidence on Optimal Multidrug-resistant
Recruiting
- Tuberculosis, Multidrug-Resistant
- HIV
- Bdq, Lzd, Lfx, Dlm, Cfz (9-12 months)
- +2 more
-
Almaty, Kazakhstan
- +2 more
May 12, 2023
Tuberculosis Trial in Shanghai, Hangzhou (Short-course regimen, Standard regimen)
Active, not recruiting
- Tuberculosis
- Short-course regimen
- Standard regimen
-
Shanghai, Shanghai, China
- +1 more
Nov 22, 2023
Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with
Not yet recruiting
- Tuberculosis, Pulmonary
- Short Regimen with Rifapentine 10mg/kg
- +3 more
-
Guiyang, Guizhou, China
- +5 more
May 28, 2022
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid
Active, not recruiting
- Tuberculosis
- +4 more
- Bedaquiline Oral Tablet
- +7 more
-
Port Elizabeth, Eastern Cape, South Africa
- +1 more
Oct 20, 2022
Latent Tuberculosis, Staphylococcus Aureus Trial in Malmö (No intervention is part of the study protocol)
Recruiting
- Latent Tuberculosis
- Staphylococcus Aureus
- No intervention is part of the study protocol
-
Malmö, SwedenSkåne University Hospital
Oct 24, 2022
Pulmonary Tuberculosis Trial in Rio de Janeiro, Rio De Janeiro (Standard care plus pulmonary rehabilitation, Standard Care)
Recruiting
- Pulmonary Tuberculosis
- Standard care plus pulmonary rehabilitation
- Standard Care
-
Rio de Janeiro, Brazil
- +1 more
Nov 7, 2023
Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)
Not yet recruiting
- Tuberculosis, Pulmonary
- Tuberculosis Infection
- Rifabutin
- +7 more
-
Denver, Colorado
- +14 more
Mar 2, 2023
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Tuberculosis, Tuberculous Meningitis, Drug-Induced Liver Injury Trial in Jakarta, Ho Chi Minh City (Dexamethasone, Placebo)
Active, not recruiting
- Tuberculosis
- +4 more
- Dexamethasone
- Placebo
-
Jakarta, Indonesia
- +5 more
Jun 29, 2022
Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))
Recruiting
- Tuberculosis Infection
- Nivaquine ® (Chloroquine)
-
Zurich, SwitzerlandClinical Trial Center
Jun 28, 2022
Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +7 more
-
Tbilisi, Georgia
- +11 more
Feb 14, 2022
Tuberculous Meningitis Trial (Xpert MTB/RIF)
Completed
- Tuberculous Meningitis
- Xpert MTB/RIF
- (no location specified)
Mar 12, 2023
Tuberculosis, Pulmonary Trial in Kaohsiung, Taipei, Taoyuan City (4-month rifapentine-based regimen)
Not yet recruiting
- Tuberculosis, Pulmonary
- 4-month rifapentine-based regimen
-
Kaohsiung, Taiwan
- +3 more
Apr 22, 2021
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy Trial in Shanghai (Group A (the standard 2HRZE/4HR regimen), Group B (New
Completed
- Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
- Group A (the standard 2HRZE/4HR regimen）
- Group B (New short course PRS regimen, 4EZ(high dose)PtoCfz)
-
Shanghai, China
- +3 more
Nov 5, 2020
Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)
Not yet recruiting
- Tuberculosis, Multidrug-Resistant
- Targeted sequencing using the GenoScreen Deeplex assay
-
Cape Town, Western Cape, South AfricaUniversity of Cape Town
Sep 28, 2021
Tuberculosis Trial in Manaus, Rio De Janeiro (Rifapentine 600 mg and INH 300 mg, Rifapentine 900 mg and INH 900 mg)
Recruiting
- Tuberculosis
- Rifapentine 600 mg and INH 300 mg
- Rifapentine 900 mg and INH 900 mg
-
Manaus, AM, Brazil
- +1 more
Apr 14, 2022
Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg
Recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Linezolid 600 mg
- +7 more
-
Gaborone, South-East District, Botswana
- +16 more
Dec 13, 2022
Hospitalized Pulmonary Tuberculosis at Strasbourg University
Recruiting
- Pulmonary Tuberculosis
-
Strasbourg, FranceCentre de Ressources et de Compétences de la Mucoviscidose (CRCM
Oct 25, 2023
Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))
Completed
- Tuberculosis
- HIV Infections
- Rifapentine (RPT)
- +2 more
-
La Jolla, California
- +44 more
Nov 2, 2021
